That was higher than its previous bid of up to $9 billion which sparked a lawsuit from pfizer. 30, novo nordisk tried to pinch metsera with an $8.5 billion offer The announcement of the deal signaled an end to the bidding war for metsera between pfizer and novo nordisk, the danish maker of ozempic and wegovy.
@lovely36j Lovely36j Channel | 24vids
Metsera accepted a sweetened offer from.
The new proposal for the coveted obesity drug developer is more than double the size of pfizer’s original bid and ends a squabble with novo nordisk that had resulted in lawsuits.
Pfizer wins $10 billion bid for metsera, securing entry into the booming obesity drug market Novo nordisk withdraws over us antitrust risks after a heated bidding war. Agreed to buy metsera inc For up to $10 billion, prevailing over novo nordisk a/s in a tumultuous bidding war after us regulatory opposition thwarted the danish drugmaker’s rival.
The deal comes three days after novo nordisk raised the stakes in its push to outbid pfizer, saying tuesday it would offer to pay as much as $10 billion for metsera. Metsera initially agreed to be acquired by pfizer in september for $4.9 billion, with additional cvrs down the line
